Jilin Jian Yisheng Pharmaceutical Co., Ltd. (SHE:002566)
China flag China · Delayed Price · Currency is CNY
8.21
-0.17 (-2.03%)
May 12, 2026, 3:04 PM CST

SHE:002566 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
234.3763.5571.48487.73343.26219.7
Short-Term Investments
-----30.08
Trading Asset Securities
400.57507.57459.67102.9859.8470.16
Cash & Short-Term Investments
634.94571.13531.15590.72403.11319.94
Cash Growth
9.74%7.53%-10.08%46.54%25.99%11.48%
Accounts Receivable
207.25214.89199.03198.53264254.84
Other Receivables
24.714.7610.5311.7522.2339.61
Receivables
231.94230.96209.56210.28286.23294.45
Inventory
1,5751,5811,6261,6171,6031,597
Other Current Assets
11.9414.78.5813.3210.1710.53
Total Current Assets
2,4542,3982,3762,4312,3032,222
Property, Plant & Equipment
407.7417.13450.34483.66526.11501.49
Long-Term Investments
-15.615.23---
Goodwill
1.911.911.911.911.911.91
Other Intangible Assets
108.13108.66111.35114.18117.03119.96
Long-Term Deferred Tax Assets
16.3915.8513.1512.6214.215.2
Long-Term Deferred Charges
1.331.542.152.023.072.99
Other Long-Term Assets
16.71.130.761.271.681.04
Total Assets
3,0062,9602,9713,0472,9672,864
Accounts Payable
13.1711.691324.8624.3319.81
Accrued Expenses
8.6722.4122.2632.5130.6848.11
Short-Term Debt
333.22308.23290.28470.43430.43397.86
Current Portion of Long-Term Debt
2.680.30.42--2.55
Current Portion of Leases
-2.42.982.343.293.31
Current Income Taxes Payable
11.90.140.012.780.645.55
Current Unearned Revenue
10.5914.775.4911.0124.5116.72
Other Current Liabilities
38.2824.1731.5545.9174.2939.84
Total Current Liabilities
418.51384.1366589.85588.16533.75
Long-Term Debt
129.7129.7149.7---
Long-Term Leases
3.445.346.214.039.8211.46
Long-Term Unearned Revenue
106.41108.87112.54118.69118.02120.85
Long-Term Deferred Tax Liabilities
2.672.342.771.741.170.02
Total Liabilities
660.73630.35637.22714.3717.18666.08
Common Stock
330.95330.95330.95330.95330.95330.95
Additional Paid-In Capital
834.69834.69834.69834.69834.69834.69
Retained Earnings
1,0821,0661,0701,068989.34916.17
Total Common Equity
2,2482,2322,2362,2332,1552,082
Minority Interest
97.8497.7697.8399.2694.45116.47
Shareholders' Equity
2,3452,3292,3332,3322,2492,198
Total Liabilities & Equity
3,0062,9602,9713,0472,9672,864
Total Debt
469.04445.97449.59476.8443.55415.18
Net Cash (Debt)
165.9125.1681.56113.92-40.44-95.24
Net Cash Growth
81.41%53.45%-28.40%---
Net Cash Per Share
0.500.380.250.34-0.12-0.29
Filing Date Shares Outstanding
330.83330.95330.95330.95330.95330.95
Total Common Shares Outstanding
330.83330.95330.95330.95330.95330.95
Working Capital
2,0362,0142,0101,8411,7141,688
Book Value Per Share
6.796.746.766.756.516.29
Tangible Book Value
2,1382,1212,1222,1172,0361,960
Tangible Book Value Per Share
6.466.416.416.406.155.92
Buildings
-548.36548.14548.14545.7400.71
Machinery
-352.2353.49359357.13321.57
Construction In Progress
----1.98119.32
Source: S&P Global Market Intelligence. Standard template. Financial Sources.